A comparative study of Agpideepan & Vyadhipratyannek chikitsa withVyadhipmtyannek chikitsa in the management of Non alcoholic fatty liver

Central Council for Research in Ayurvedic Sciences0 个研究点目标入组 0 人开始时间: 待定最近更新: 2022年6月27日

试验速览

暂无简介。

•1.Either sex aged between 18-65 years.
•2.Diagnosed cases of Grade- I&II of non-alcoholic fatty liver disease as evident by fatty infiltration by Ultrasound evaluation (USG Abdomen)
•3.Participants having BMI from 18.5 to 30
•4.Subjects of non-alcoholic fatty liver disease with their hepatic enzymes <2 times upper normal limit.
•5.Willing to provide informed consent and able to participate for 3 months in the study.

•1.Any other identified cause of chronic liver disease or already taking supplementary medicine for NAFLD.
•2.H/O habitual consumption of alcohol intake of >20g/day for women, >40g/day for men
•3.Subjects who have a past history of Cardiac Arrhythmia, Acute Coronary Syndrome, Myocardial Infarction, Stroke or Severe Arrhythmia in the last 6 months.
•4.Known case of malignancy, concurrent Renal Dysfunction, uncontrolled Pulmonary Dysfunction (asthmatic and COPD patients), Neurological disorders, severe psychiatric disorders, endocrinology or other concurrent severe disease.
•5.Uncontrolled Diabetes Mellitus(HbA1C >8)
•6.Subjects taking participation in any other clinical trial.
•7.Pregnant or lactating women
•8.Any other condition which PI think can jeopardize the study

发起方